UPDATE 1-MoonLake's psoriatic arthritis drug meets key goals in late-stage trial

(Adds shares in paragraph 2, analyst comments in bullets 6 and 7) By Padmanabhan Ananthan Aug 10 (Reuters) – MoonLake Immunotherapeutics said on Monday its experimental drug met all main goals in a

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)